サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421753

バイオマーカー探索アウトソーシングサービス市場、シェア、規模、動向、産業分析レポート：タイプ別、治療領域別、探索フェーズ別、最終用途別、地域別、セグメント別予測、2023年～2032年

Biomarker Discovery Outsourcing Services Market Share, Size, Trends, Industry Analysis Report, By Type; By Therapeutic Area ; By Discovery Phase; By End-use; By Region, And Segment Forecasts, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
バイオマーカー探索アウトソーシングサービス市場、シェア、規模、動向、産業分析レポート：タイプ別、治療領域別、探索フェーズ別、最終用途別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年12月23日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、バイオマーカー探索アウトソーシングサービスの世界市場規模は2032年までに704億4,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

臨床試験におけるバイオマーカーの利用が増加し、製薬企業によるバイオマーカー調査サービスのアウトソーシング需要が高まっています。また、製薬業界ではバイオマーカー調査を含め、業務のさまざまな側面をアウトソーシングする傾向が強まっており、市場の拡大に寄与しています。また、血液、尿、脳脊髄液などの体液中のバイオマーカーを分析する技術であるリキッドバイオプシーの採用が拡大していることも原動力となっています。リキッドバイオプシーは、従来の組織生検に比べて侵襲性が低く、リアルタイムで情報が得られるという利点があります。リキッドバイオプシーの人気が高まるにつれて、バイオマーカー探索アウトソーシングサービスに対する需要も増加しており、市場成長の極めて重要な要因となっています。

医薬品開発と臨床試験の増加により、市場は大きな成長を遂げています。バイオマーカーは医薬品開発において極めて重要なものとなっており、製薬会社が適切な創薬標的をピンポイントで特定し、臨床試験手順を合理化し、試験に適した患者集団を特定する上で役立っています。2023年現在、世界の臨床試験の状況は、ClinicalTrials.govに452,604件の臨床試験が登録され、64,838人が積極的に参加者を登録しています。これは、2021年初頭に指摘された約365,000件の登録試験と比較して大幅な増加を示しており、臨床研究の領域における強固で継続的な拡大を浮き彫りにしています。

バイオマーカー探索の将来は、オミックス技術の進歩に大きく依存しています。ゲノミクス、プロテオミクス、メタボロミクス、その他のオミクス分野は著しい進歩を遂げ、科学者は新たなバイオマーカーを同定できるようになった。これらの様々なオミックス分野のデータを統合することは、バイオマーカー同定にとって非常に有益です。ゲノミクス、プロテオミクス、メタボロミクスからの知見を組み合わせることで、研究者は複雑な疾患を包括的に理解することができます。

マルチオミクス・データ統合を専門とするアウトソーシング・サービスは、このプロセスにおいて重要な役割を果たします。このような専門サービス・プロバイダーは、さまざまなオミックス・データの複雑性をナビゲートし、それらを効果的に統合する専門知識を持っています。バイオマーカー探索をこうした専門家に委託することで、製薬会社や研究機関は最新の技術や手法を活用することができ、ヘルスケア分野における診断や調査手法の進歩に不可欠な革新的バイオマーカーの同定につなげることができます。

バイオマーカー探索アウトソーシングサービス市場レポートハイライト

サロゲートエンドポイントは、薬剤の作用機序を正確に把握し、個別化治療への道を開くことから、市場を独占しています。

がん患者数の増加とがん研究への投資により、がん領域が最大シェアを占める

北米は、巨大な産学ネットワーク、研究資金の存在、計算生物学に携わる主要企業を擁していることから、市場を独占しています。

主な市場プレイヤーは、Laboratory Corporation of America、Charles River Laboratories、Eurofins Scientific、Celerion、ICON、Parexel、Proteome Sciencesなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界バイオマーカー探索アウトソーシングサービス市場洞察

  • バイオマーカー検出アウトソーシングサービス-業界スナップショット
  • バイオマーカー探索アウトソーシングサービス市場力学
    • 促進要因と機会
      • 個別化医療と標的療法への注目が高まる
      • ハイスループットオミクス技術の進歩
    • 抑制要因と課題
      • バイオマーカーの検証と臨床的有用性についての理解が限られている
  • PESTLE分析
  • バイオマーカー探索アウトソーシングサービスの業界動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のバイオマーカー探索アウトソーシングサービス市場、治療領域別

  • 主な調査結果
  • イントロダクション
  • 腫瘍学
  • 神経内科
  • 心臓病学
  • 自己免疫疾患
  • その他

第6章 世界のバイオマーカー探索アウトソーシングサービス市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 予測バイオマーカー
  • 予後バイオマーカー
  • 安全性バイオマーカー
  • サロゲートエンドポイント

第7章 世界のバイオマーカー探索アウトソーシングサービス市場、探索フェーズ別

  • 主な調査結果
  • イントロダクション
  • バイオマーカーの同定
  • バイオマーカーの検証
  • バイオマーカープロファイリング
  • バイオマーカーパネルの開発
  • バイオマーカーの選択

第8章 世界のバイオマーカー探索アウトソーシングサービス市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 製薬会社
  • バイオテクノロジー企業
  • その他

第9章 世界のバイオマーカー探索アウトソーシングサービス市場、地域別

  • 主な調査結果
  • イントロダクション
    • バイオマーカー探索アウトソーシングサービス市場評価、地域、2019-2032年
  • バイオマーカー探索アウトソーシングサービス市場-北米
    • 北米：バイオマーカー探索アウトソーシングサービス市場、治療分野別、2019-2032年
    • 北米：バイオマーカー探索アウトソーシングサービス市場、最終用途別、2019-2032年
    • 北米：バイオマーカー探索アウトソーシングサービス市場、タイプ別、2019-2032年
    • 北米：バイオマーカー探索アウトソーシングサービス市場、探索フェーズ別、2019年～2032年
    • バイオマーカー探索アウトソーシングサービス市場-米国
    • バイオマーカー探索アウトソーシングサービス市場- カナダ
  • バイオマーカー探索アウトソーシングサービス市場- 欧州
    • 欧州：バイオマーカー探索アウトソーシングサービス市場、治療分野別、2019～2032年
    • 欧州：バイオマーカー探索アウトソーシングサービス市場、最終用途別、2019～2032年
    • 欧州：バイオマーカー探索アウトソーシングサービス市場、タイプ別、2019～2032年
    • 欧州：バイオマーカー探索アウトソーシングサービス市場、探索フェーズ別、2019年～2032年
    • バイオマーカー探索アウトソーシングサービス市場- 英国
    • バイオマーカー探索アウトソーシングサービス市場- フランス
    • バイオマーカー探索アウトソーシングサービス市場- ドイツ
    • バイオマーカー探索アウトソーシングサービス市場- イタリア
    • バイオマーカー探索アウトソーシングサービス市場- スペイン
    • バイオマーカー探索アウトソーシングサービス市場- オランダ
    • バイオマーカー探索アウトソーシングサービス市場- ロシア
  • バイオマーカー探索アウトソーシングサービス市場- アジア太平洋
    • アジア太平洋：バイオマーカー探索アウトソーシングサービス市場、治療分野別、2019～2032年
    • アジア太平洋：バイオマーカー探索アウトソーシングサービス市場、最終用途別、2019～2032年
    • アジア太平洋：バイオマーカー探索アウトソーシングサービス市場、タイプ別、2019～2032年
    • アジア太平洋：バイオマーカー探索アウトソーシングサービス市場、探索フェーズ別、2019～2032年
    • バイオマーカー探索アウトソーシングサービス市場- 中国
    • バイオマーカー探索アウトソーシングサービス市場- インド
    • バイオマーカー探索アウトソーシングサービス市場- 日本
    • バイオマーカー探索アウトソーシングサービス市場- マレーシア
    • バイオマーカー探索アウトソーシングサービス市場- インドネシア
    • バイオマーカー探索アウトソーシングサービス市場- 韓国
  • バイオマーカー探索アウトソーシングサービス市場-中東およびアフリカ
    • 中東およびアフリカ：バイオマーカー探索アウトソーシングサービス市場、治療分野別、2019～2032年
    • 中東およびアフリカ：バイオマーカー探索アウトソーシングサービス市場、最終用途別、2019～2032年
    • 中東およびアフリカ：バイオマーカー探索アウトソーシングサービス市場、タイプ別、2019～2032年
    • 中東およびアフリカ：バイオマーカー探索アウトソーシングサービス市場、発見段階別、2019～2032年
    • バイオマーカー探索アウトソーシングサービス市場- サウジアラビア
    • バイオマーカー探索アウトソーシングサービス市場- 南アフリカ
    • バイオマーカー探索アウトソーシングサービス市場- イスラエル
    • バイオマーカー探索アウトソーシングサービス市場- アラブ首長国連邦
  • バイオマーカー探索アウトソーシングサービス市場-ラテンアメリカ
    • ラテンアメリカ：バイオマーカー探索アウトソーシングサービス市場、治療分野別、2019-2032年
    • ラテンアメリカ：バイオマーカー探索アウトソーシングサービス市場、最終用途別、2019-2032年
    • ラテンアメリカ：バイオマーカー探索アウトソーシングサービス市場、タイプ別、2019-2032年
    • ラテンアメリカ：バイオマーカー探索アウトソーシングサービス市場、発見段階別、2019年～2032年
    • バイオマーカー探索アウトソーシングサービス市場- メキシコ
    • バイオマーカー探索アウトソーシングサービス市場- ブラジル
    • バイオマーカー探索アウトソーシングサービス市場- アルゼンチン

第10章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Laboratory Corporation of America Holdings
  • Charles River Laboratories
  • Eurofins Scientific
  • Celerion
  • ICON plc
  • Parexel International（MA）Corporation
  • Proteome Sciences
  • GHO Capital
  • Thermo Fisher Scientific Inc.
  • Evotec
図表

List of Tables

  • Table 1 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Biomarker Discovery Outsourcing Services Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Biomarker Discovery Outsourcing Services Market, by End Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 7 North America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 8 North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 9 North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 11 U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 13 U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 15 Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 17 Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 18 Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 19 Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 21 Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 22 Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 23 Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 25 Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 27 France: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 28 France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 29 France: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 30 UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 31 UK: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 32 UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 33 UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 34 Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 35 Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 37 Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 42 Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 43 Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 44 Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 45 Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 46 Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 47 Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 49 Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 54 China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 55 China: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 56 China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 57 China: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 58 Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 59 Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 61 Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 63 India: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 64 India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 65 India: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 75 South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 76 South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 77 South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 78 Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 79 Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 80 Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 81 Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 82 Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 83 Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 85 Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 86 Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 87 Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 88 Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 89 Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 90 Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 91 Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 92 Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 93 Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 98 UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 99 UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 100 UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 101 UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 106 South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 107 South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 108 South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 109 South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • Table 110 Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 111 Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • Table 113 Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Biomarker Discovery Outsourcing Services Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End Use
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutic Area
  • Figure 7. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Type
  • Figure 11. Global Biomarker Discovery Outsourcing Services Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Discovery Phase
  • Figure 13. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2021 & 2030 (USD Billion)
目次
Product Code: PM4075

The global biomarker discovery outsourcing services market size is expected to reach USD 70.44 billion by 2032, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Share, Size, Trends, Industry Analysis Report, By Type; By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, Others); By Discovery Phase; By End-use; By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising use of biomarkers in clinical trials, leading to an increased demand for outsourced biomarker research services by pharmaceutical companies. Additionally, the pharmaceutical industry is increasingly outsourcing various aspects of its operations, including biomarker research, contributing to the market's expansion. Another driving force is the growing adoption of liquid biopsies, a technique that involves analyzing biomarkers in bodily fluids like blood, urine, and cerebrospinal fluid. Liquid biopsies offer advantages over traditional tissue biopsies, being less invasive and providing real-time information. As the popularity of liquid biopsies rises, the demand for biomarker discovery outsourcing services is also increasing, making it a pivotal factor in the market's growth.

The market is experiencing significant growth due to the rise in drug development and clinical trials. Biomarkers have become pivotal in drug development, aiding pharmaceutical companies in pinpointing appropriate drug targets, streamlining clinical trial procedures, and identifying suitable patient populations for trials. As of 2023, the global clinical trial landscape boasts an impressive 452,604 registered trials on ClinicalTrials.gov, with 64,838 actively enrolling participants. This marks a substantial increase compared to the approximately 365,000 registered trials noted in early 2021, highlighting the robust and continuous expansion within the realm of clinical research.

The future of biomarker discovery is heavily reliant on advancements in omics technologies. Genomics, proteomics, metabolomics, and other omics disciplines have made significant progress, allowing scientists to identify new biomarkers. Integrating data from these various omics fields is incredibly beneficial for biomarker identification. By combining insights from genomics, proteomics, and metabolomics, researchers can gain a comprehensive understanding of complex disorders.

Outsourcing services that specialize in multi-omics data integration play a crucial role in this process. These specialized service providers have the expertise to navigate the complexities of different omics data and integrate them effectively. By outsourcing biomarker discovery efforts to these experts, pharmaceutical companies and research institutions can leverage the latest technologies and methodologies, leading to the identification of innovative biomarkers essential for advancing diagnostics and therapeutics in the field of healthcare.

Biomarker Discovery and Outsourcing Services Market Report Highlights

Surrogate endpoints dominated the market, as they precise drug's mechanism of action, paving the way for personalized therapies.

The oncology segment held the largest share, owing to rising cases of cancer and investments in cancer research

North America dominated the market, as it possesses a huge industry-academia network, the presence of research funding, and key companies involved in computational biology

The key market players include Laboratory Corporation of America, Charles River Laboratories, Eurofins Scientific, Celerion, ICON, Parexel, and Proteome Sciences

Polaris Market Research has segmented the biomarker discovery and outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:

Biomarker Discovery and Outsourcing Services, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Predictive biomarkers
  • Prognostic biomarkers
  • Safety biomarkers
  • Surrogate endpoints

Biomarker Discovery and Outsourcing Services, Therapeutic Area Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oncology
  • Neurology
  • Cardiology
  • Autoimmune Diseases
  • Others

Biomarker Discovery and Outsourcing Services, Discovery Phase Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biomarker Identification
  • Biomarker Validation
  • Biomarker Profiling
  • Biomarker Panel Development
  • Biomarker Selection

Biomarker Discovery and Outsourcing Services, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others

Biomarker Discovery and Outsourcing Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biomarker Discovery Outsourcing Services Market Insights

  • 4.1. Biomarker Discovery Outsourcing Services - Industry Snapshot
  • 4.2. Biomarker Discovery Outsourcing Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing focus on personalized medicine and targeted therapies
      • 4.2.1.2. Advancements in high-throughput omics technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. limited understanding of biomarker validation and clinical utility
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Biomarker Discovery Outsourcing Services Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Global Biomarker Discovery Outsourcing Services Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 5.4. Neurology
    • 5.4.1. Global Biomarker Discovery Outsourcing Services Market, by Neurology, by Region, 2019-2032 (USD Billion)
  • 5.5. Cardiology
    • 5.5.1. Global Biomarker Discovery Outsourcing Services Market, by Cardiology, by Region, 2019-2032 (USD Billion)
  • 5.6. Autoimmune Diseases
    • 5.6.1. Global Biomarker Discovery Outsourcing Services Market, by Autoimmune Diseases, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Biomarker Discovery Outsourcing Services Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Predictive biomarkers
    • 6.3.1. Global Biomarker Discovery Outsourcing Services Market, by Predictive biomarkers, by Region, 2019-2032 (USD Billion)
  • 6.4. Prognostic biomarkers
    • 6.4.1. Global Biomarker Discovery Outsourcing Services Market, by Prognostic biomarkers, by Region, 2019-2032 (USD Billion)
  • 6.5. Safety biomarkers
    • 6.5.1. Global Biomarker Discovery Outsourcing Services Market, by Safety biomarkers, by Region, 2019-2032 (USD Billion)
  • 6.6. Surrogate endpoints
    • 6.6.1. Global Biomarker Discovery Outsourcing Services Market, by Surrogate endpoints, by Region, 2019-2032 (USD Billion)

7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 7.3. Biomarker Identification
    • 7.3.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Identification, by Region, 2019-2032 (USD Billion)
  • 7.4. Biomarker Validation
    • 7.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Validation, by Region, 2019-2032 (USD Billion)
  • 7.5. Biomarker Profiling
    • 7.5.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Profiling, by Region, 2019-2032 (USD Billion)
  • 7.6. Biomarker Panel Development
    • 7.6.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Panel Development, by Region, 2019-2032 (USD Billion)
  • 7.7. Biomarker Selection
    • 7.7.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Selection, by Region, 2019-2032 (USD Billion)

8. Global Biomarker Discovery Outsourcing Services Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • 8.3. Pharmaceutical Companies
    • 8.3.1. Global Biomarker Discovery Outsourcing Services Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
  • 8.4. Biotechnology Companies
    • 8.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biotechnology Companies, by Region, 2019-2032 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Biomarker Discovery Outsourcing Services Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Biomarker Discovery Outsourcing Services Market - North America
    • 9.3.1. North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.3.2. North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.3.3. North America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.3.4. North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.3.5. Biomarker Discovery Outsourcing Services Market - U.S.
      • 9.3.5.1. U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.3.6. Biomarker Discovery Outsourcing Services Market - Canada
      • 9.3.6.1. Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4. Biomarker Discovery Outsourcing Services Market - Europe
    • 9.4.1. Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.5. Biomarker Discovery Outsourcing Services Market - UK
      • 9.4.5.1. UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.6. Biomarker Discovery Outsourcing Services Market - France
      • 9.4.6.1. France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.7. Biomarker Discovery Outsourcing Services Market - Germany
      • 9.4.7.1. Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.8. Biomarker Discovery Outsourcing Services Market - Italy
      • 9.4.8.1. Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.9. Biomarker Discovery Outsourcing Services Market - Spain
      • 9.4.9.1. Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.10. Biomarker Discovery Outsourcing Services Market - Netherlands
      • 9.4.10.1. Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.4.11. Biomarker Discovery Outsourcing Services Market - Russia
      • 9.4.11.1. Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.5. Biomarker Discovery Outsourcing Services Market - Asia Pacific
    • 9.5.1. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.5. Biomarker Discovery Outsourcing Services Market - China
      • 9.5.5.1. China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.6. Biomarker Discovery Outsourcing Services Market - India
      • 9.5.6.1. India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.7. Biomarker Discovery Outsourcing Services Market - Japan
      • 9.5.7.1. Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.8. Biomarker Discovery Outsourcing Services Market - Malaysia
      • 9.5.8.1. Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.9. Biomarker Discovery Outsourcing Services Market - Indonesia
      • 9.5.9.1. Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.5.10. Biomarker Discovery Outsourcing Services Market - South Korea
      • 9.5.10.1. South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.6. Biomarker Discovery Outsourcing Services Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.6.5. Biomarker Discovery Outsourcing Services Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.6.6. Biomarker Discovery Outsourcing Services Market - South Africa
      • 9.6.6.1. South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.6.7. Biomarker Discovery Outsourcing Services Market - Israel
      • 9.6.7.1. Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.6.8. Biomarker Discovery Outsourcing Services Market - UAE
      • 9.6.8.1. UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.7. Biomarker Discovery Outsourcing Services Market - Latin America
    • 9.7.1. Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.7.5. Biomarker Discovery Outsourcing Services Market - Mexico
      • 9.7.5.1. Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.7.6. Biomarker Discovery Outsourcing Services Market - Brazil
      • 9.7.6.1. Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
    • 9.7.7. Biomarker Discovery Outsourcing Services Market - Argentina
      • 9.7.7.1. Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Laboratory Corporation of America Holdings
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Charles River Laboratories
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Eurofins Scientific
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Celerion
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. ICON plc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Parexel International (MA) Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Proteome Sciences
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. GHO Capital
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Thermo Fisher Scientific Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Evotec
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development